2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery …
G Hindricks, T Potpara, N Dagres, E Arbelo… - European heart …, 2021 - academic.oup.com
MicroRNAs (miRNAs) are small regulatory molecules post-transcriptionally suppressing
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
J Steffel, P Verhamme, TS Potpara… - European heart …, 2018 - academic.oup.com
The current manuscript is the second update of the original Practical Guide, published in
2013 [Heidbuchel et al. European Heart Rhythm Association Practical Guide on the use of …
2013 [Heidbuchel et al. European Heart Rhythm Association Practical Guide on the use of …
The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society comprehensive guidelines for the management of atrial fibrillation
JG Andrade, M Aguilar, C Atzema, A Bell… - Canadian Journal of …, 2020 - Elsevier
Abstract The Canadian Cardiovascular Society (CCS) atrial fibrillation (AF) guidelines
program was developed to aid clinicians in the management of these complex patients, as …
program was developed to aid clinicians in the management of these complex patients, as …
Mortality in patients with atrial fibrillation receiving nonrecommended doses of direct oral anticoagulants
AJ Camm, F Cools, S Virdone, JP Bassand… - Journal of the American …, 2020 - jacc.org
Background The recommended doses for direct oral anticoagulants (DOACs) to prevent
stroke and systemic embolism (SE) in patients with atrial fibrillation (AF) are described in …
stroke and systemic embolism (SE) in patients with atrial fibrillation (AF) are described in …
[HTML][HTML] Mobile health technology for atrial fibrillation management integrating decision support, education, and patient involvement: mAF app trial
Y Guo, Y Chen, DA Lane, L Liu, Y Wang… - The American journal of …, 2017 - Elsevier
Abstract Background Mobile Health technology for the management of patients with atrial
fibrillation is unknown. Methods The simple mobile AF (mAF) App was designed to …
fibrillation is unknown. Methods The simple mobile AF (mAF) App was designed to …
Influence of direct oral anticoagulants on rates of oral anticoagulation for atrial fibrillation
Background: Oral anticoagulation (OAC) with warfarin is underused for atrial fibrillation (AF).
The availability of direct oral anticoagulants (DOACs) may improve overall OAC rates in AF …
The availability of direct oral anticoagulants (DOACs) may improve overall OAC rates in AF …
A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial
Background Oral anticoagulation is underused in patients with atrial fibrillation. We
assessed the impact of a multifaceted educational intervention, versus usual care, on oral …
assessed the impact of a multifaceted educational intervention, versus usual care, on oral …
Integrated care in atrial fibrillation: a systematic review and meta-analysis
Objective Atrial fibrillation (AF) is an emerging global epidemic associated with significant
morbidity and mortality. Whilst other chronic cardiovascular conditions have demonstrated …
morbidity and mortality. Whilst other chronic cardiovascular conditions have demonstrated …
Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without …
KAA Fox, JE Lucas, KS Pieper, JP Bassand… - BMJ open, 2017 - bmjopen.bmj.com
Objectives To provide an accurate, web-based tool for stratifying patients with atrial
fibrillation to facilitate decisions on the potential benefits/risks of anticoagulation, based on …
fibrillation to facilitate decisions on the potential benefits/risks of anticoagulation, based on …
Real-world use of apixaban for stroke prevention in atrial fibrillation: a systematic review and meta-analysis
Background and Purpose—The use of oral anticoagulant therapy for stroke prevention in
atrial fibrillation has been transformed by the availability of the nonvitamin K antagonist oral …
atrial fibrillation has been transformed by the availability of the nonvitamin K antagonist oral …